Systematic review of the efficacy, effectiveness and safety of high-dose seasonal influenza vaccines for the prevention of laboratory-confirmed influenza in individuals ≥18 years of age.

Autor: Comber L; Health Information and Quality Authority (HIQA), Dublin, Ireland., O Murchu E; Health Information and Quality Authority (HIQA), Dublin, Ireland.; Department of Health Policy & Management, School of Medicine, Trinity College Dublin, Dublin, Ireland., Jordan K; Health Information and Quality Authority (HIQA), Dublin, Ireland., Hawkshaw S; Health Information and Quality Authority (HIQA), Dublin, Ireland., Marshall L; Health Information and Quality Authority (HIQA), Dublin, Ireland., O'Neill M; Health Information and Quality Authority (HIQA), Dublin, Ireland., Teljeur C; Health Information and Quality Authority (HIQA), Dublin, Ireland., Ryan M; Health Information and Quality Authority (HIQA), Dublin, Ireland.; Department of Pharmacology & Therapeutics, Trinity College Dublin, Trinity Health Sciences, Dublin, Ireland., Carnahan A; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) Collaboration on Newer and Enhanced Inactivated Seasonal Influenza Vaccines, Solna, Sweden.; Public Health Agency of Sweden, Solna, Sweden., Pérez Martín JJ; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) Collaboration on Newer and Enhanced Inactivated Seasonal Influenza Vaccines, Solna, Sweden.; General Directorate of Public Health and Addictions, IMIB-Arrixaca, Murcia University, Region of Murcia, Spain., Robertson AH; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) Collaboration on Newer and Enhanced Inactivated Seasonal Influenza Vaccines, Solna, Sweden.; Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway., Johansen K; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) Collaboration on Newer and Enhanced Inactivated Seasonal Influenza Vaccines, Solna, Sweden.; European Centre for Disease Prevention and Control, Stockholm, Sweden., de Jonge J; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) Collaboration on Newer and Enhanced Inactivated Seasonal Influenza Vaccines, Solna, Sweden.; National Institute for Public Health and the Environment, Center for Infectious Disease Control, Bilthoven, The Netherlands., Krause T; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) Collaboration on Newer and Enhanced Inactivated Seasonal Influenza Vaccines, Solna, Sweden.; Statens Serum Institut, Copenhagen, Denmark., Nicolay N; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) Collaboration on Newer and Enhanced Inactivated Seasonal Influenza Vaccines, Solna, Sweden.; European Centre for Disease Prevention and Control, Stockholm, Sweden., Nohynek H; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) Collaboration on Newer and Enhanced Inactivated Seasonal Influenza Vaccines, Solna, Sweden.; Finnish Institute for Health and Welfare, Helsinki, Finland., Pavlopoulou I; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) Collaboration on Newer and Enhanced Inactivated Seasonal Influenza Vaccines, Solna, Sweden.; Pediatric Research Laboratory, School of Health Sciences, Faculty of Nursing, National & Kapodistrian University of Athens, Goudi, Greece.; National Advisory Committee on Immunisation, Hellenic Ministry of Health, Athens, Greece., Pebody R; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) Collaboration on Newer and Enhanced Inactivated Seasonal Influenza Vaccines, Solna, Sweden.; Institute of Epidemiology & Health, University College London, London, UK., Penttinen P; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) Collaboration on Newer and Enhanced Inactivated Seasonal Influenza Vaccines, Solna, Sweden.; European Centre for Disease Prevention and Control, Stockholm, Sweden., Soler-Soneira M; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) Collaboration on Newer and Enhanced Inactivated Seasonal Influenza Vaccines, Solna, Sweden.; Vigilancia de Enfermedades Prevenibles por Vacunación, Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación, Madrid, Spain., Wichmann O; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) Collaboration on Newer and Enhanced Inactivated Seasonal Influenza Vaccines, Solna, Sweden.; Immunization Unit, Robert Koch-Institute, Berlin, Germany., Harrington P; Health Information and Quality Authority (HIQA), Dublin, Ireland.

Publikováno v: Reviews in medical virology [Rev Med Virol] 2023 May; Vol. 33 (3), pp. e2330. Date of Electronic Publication: 2022 Feb 04.

EE828 Developing Automated Decision Rules Based on Vaccine Cost to Identify Optimal Vaccination Strategies

Autor: Ahern, S ¹, Bergin, A ¹, Cardwell, K ¹, Harrington, P ², Teljeur, C ², Ryan, M ¹

Publikováno v: In Value in Health December 2024 27(12) Supplement:S217-S218

Chronic respiratory disease and multimorbidity: Prevalence and impact in a general practice setting

Autor: O’Kelly, S., Smith, S.M., Lane, S., Teljeur, C., O’Dowd, T.

Publikováno v: In Respiratory Medicine 2011 105(2):236-242

Systematic review of the efficacy, effectiveness and safety of MF59® adjuvanted seasonal influenza vaccines for the prevention of laboratory-confirmed influenza in individuals ≥18 years of age

Autor: O Murchu, E. Comber, L. Jordan, K. Hawkshaw, S. Marshall, L. O’Neill, M. Ryan, M. Teljeur, C. Carnahan, A. Pérez, J.J. Robertson, A.H. Johansen, K. Jonge, J.D. Krause, T. Nicolay, N. Nohynek, H. Pavlopoulou, I. Pebody, R. Penttinen, P. Soler-Soneira, M. Wichmann, O. Harrington, P.

The most effective means of preventing seasonal influenza is through vaccination. In this systematic review, we investigated the efficacy, effectiveness and safety of MF59® adjuvanted trivalent and quadrivalent influenza vaccines to prevent laborato

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::0d6ef72ed2a6034a7aca6962258a100b
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3003159

Cost-effectiveness of metabolic surgery for the treatment of type 2 diabetes and obesity: a systematic review of economic evaluations.

Autor: Jordan K; RCSI University of Medicine and Health Sciences, Dublin, Ireland. kjordan@rcsi.ie.; Health Information and Quality Authority, Dublin, Ireland. kjordan@rcsi.ie., Fawsitt CG; Health Information and Quality Authority, Dublin, Ireland., Carty PG; RCSI University of Medicine and Health Sciences, Dublin, Ireland.; Health Information and Quality Authority, Dublin, Ireland., Clyne B; Health Information and Quality Authority, Dublin, Ireland.; Department of General Practice, Royal College of Surgeons in Ireland, Dublin, Ireland., Teljeur C; Health Information and Quality Authority, Dublin, Ireland., Harrington P; Health Information and Quality Authority, Dublin, Ireland., Ryan M; Health Information and Quality Authority, Dublin, Ireland.; Department of Pharmacology and Therapeutics, Trinity College Dublin, Trinity Health Sciences, St James's Hospital, Dublin 8, Ireland.

Publikováno v: The European journal of health economics : HEPAC : health economics in prevention and care [Eur J Health Econ] 2023 Jun; Vol. 24 (4), pp. 575-590. Date of Electronic Publication: 2022 Jul 22.